{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "29813093", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "29"}], "Language": ["eng"], "ELocationID": ["e0197736", "10.1371/journal.pone.0197736"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "13", "Issue": "5", "PubDate": {"Year": "2018"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Effects of medical ozone upon healthy equine joints: Clinical and laboratorial aspects.", "Pagination": {"StartPage": "e0197736", "MedlinePgn": "e0197736"}, "Abstract": {"AbstractText": ["The aim of this study was to verify whether transient inflammatory reactions induced by intra-articular medicinal ozone administration affect joint components, by in vivo evaluation of inflammatory (prostaglandin E2, Substance P, Interleukin-6, Interleukine-1, Tumor Necrosis Factor), anti-inflammatory (Interleukin-10) and oxidative (superoxide dismutase activity and oxidative burst) biomarkers and extracellular matrix degradation products (chondroitin sulphate and hyaluronic acid) in synovial fluid.", "The effects of medicinal ozone were analyzed at two ozone concentrations (groups A and B, 20 and 40 \u03bcg/ml, respectively), using oxygen-injected joints as controls (group C); each group received ten treatments (15 ml gas per treatment). Physical evaluation, evaluation of lameness, ultrasonography, and synovial fluid analysis were performed.", "All joints presented mild and transient effusion throughout the study. Group B exhibited the highest lameness score on day 14 (P<0.05), detected by the lameness measurement system, probably because of the higher ozone concentration. All groups exhibited increased ultrasonography scores on day 14 (P < 0.05). Groups A and B exhibited increased proteins concentrations on day 21 (P<0.05). There was no change in hyaluronic acid concentration or the percentage of high-molecular weight hyaluronic acid throughout the experiment. Chondroitin sulfate concentrations decreased in group B, and did not change in group A and C, indicating that neither treatment provoked extracellular matrix catabolism. Cytokine and eicosanoid concentrations were not significantly changed.", "The ozonetherapy did not cause significant inflammation process or cartilage degradation, therefore, ozonetherapy is safe at both evaluated doses."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": ["0000-0001-8377-5116"], "LastName": "Vendruscolo", "ForeName": "Cynthia do Prado", "Initials": "CDP"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Moreira", "ForeName": "Juliana Junqueira", "Initials": "JJ"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Seidel", "ForeName": "Sarah Raphaela Torquato", "Initials": "SRT"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "F\u00fclber", "ForeName": "Joice", "Initials": "J"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Neuenschwander", "ForeName": "Henrique Macedo", "Initials": "HM"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Large Animals Clinics, Anhembi Morumbi University, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Bonagura", "ForeName": "Giancarlo", "Initials": "G"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": ["0000-0003-3106-8967"], "LastName": "Agreste", "ForeName": "Fernanda Rodrigues", "Initials": "FR"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Medicine, School of Veterinary Medicine and Animals Science, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}], "Identifier": [], "LastName": "Baccarin", "ForeName": "Raquel Yvonne Arantes", "Initials": "RYA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Eicosanoids"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9004-61-9", "NameOfSubstance": "Hyaluronic Acid"}, {"RegistryNumber": "9007-28-7", "NameOfSubstance": "Chondroitin Sulfates"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chondroitin Sulfates"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["metabolism"], "DescriptorName": "Eicosanoids"}, {"QualifierName": ["chemically induced", "diagnostic imaging", "metabolism"], "DescriptorName": "Horse Diseases"}, {"QualifierName": [], "DescriptorName": "Horses"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hyaluronic Acid"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Joints"}, {"QualifierName": ["chemically induced", "diagnostic imaging", "metabolism"], "DescriptorName": "Lameness, Animal"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Synovial Fluid"}, {"QualifierName": ["veterinary"], "DescriptorName": "Ultrasonography"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, et al.\nThe contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J. Elsevier Ltd; 2009;179: 10\u201324. doi: 10.1016/j.tvjl.2007.08.013\n", "ArticleIdList": ["10.1016/j.tvjl.2007.08.013", "17911037"]}, {"Citation": "McIlwraith CW. The use of intra-articular corticosteroids in the horse: What is known on a scientific basis?\nEquine Vet J. 2010;42: 563\u2013571. doi: 10.1111/j.2042-3306.2010.00095.x\n", "ArticleIdList": ["10.1111/j.2042-3306.2010.00095.x", "20716199"]}, {"Citation": "Rousseau JC, Garnero P. Biological markers in osteoarthritis. Bone. Elsevier Inc.; 2012;51: 265\u2013277. doi: 10.1016/j.bone.2012.04.001\n", "ArticleIdList": ["10.1016/j.bone.2012.04.001", "22538364"]}, {"Citation": "Trumble TN. The use of nutraceuticals for osteoarthritis in horses. Vet Clin North Am\u2014Equine Pract. 2005;21: 575\u2013597. doi: 10.1016/j.cveq.2005.08.004\n", "ArticleIdList": ["10.1016/j.cveq.2005.08.004", "16297722"]}, {"Citation": "Wheat JD. The use of hydrocortisone in the treatment of joint and tendon disorders in large animals.\u2014PubMed\u2014NCBI. J Am Vet Med Assoc. 1955;127: 64\u201367. Available: https://www.ncbi.nlm.nih.gov/pubmed/14392110\n", "ArticleIdList": ["14392110"]}, {"Citation": "Bocci V. Ozone: A New Medical Drug. 1a edi\u00e7\u00e3o Dordrecht: Springer; 2005."}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37: 425\u201335. doi: 10.1016/j.arcmed.2005.08.006\n", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Schwartz A, Mart\u00ednez-s\u00e1nchez G. Ozone Therapy and Its Scientific Foundations. Rev Espa\u00f1ola Ozonioterapia. 2012;2: 199\u2013232."}, {"Citation": "Sagai M, Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?\nMed Gas Res. BioMed Central Ltd; 2011;1: 29\ndoi: 10.1186/2045-9912-1-29\n", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Buric J, Rigobello L, Hooper D. Five and ten year follow-up on intradiscal ozone injection for disc herniation. Int J spine Surg. International Society for the Advancement of Spine Surgery; 2014;8: 17\ndoi: 10.14444/1017\n", "ArticleIdList": ["10.14444/1017", "PMC4325503", "25694935"]}, {"Citation": "Oguz E, Ekinci S, Eroglu M, Bilgic S, Koca K, Durusu M, et al.\nEvaluation and comparison of the effects of hyperbaric oxygen and ozonized oxygen as adjuvant treatments in an experimental osteomyelitis model. J Surg Res. 2011;171: 61\u20138. doi: 10.1016/j.jss.2011.06.029\n", "ArticleIdList": ["10.1016/j.jss.2011.06.029", "21920551"]}, {"Citation": "Borrelli E, Bocci V. Oxygen ozone therapy in the treatment of chronic obstructive pulmonary disease\u202f: An integrative approach. 2014;2: 9\u201313. doi: 10.11648/j.ajcem.20140202.11", "ArticleIdList": ["10.11648/j.ajcem.20140202.11"]}, {"Citation": "Xi-bing GU, Xiao-juan Y, Hong-ying ZHU, Yue-qin XU, Xia-ying LIU, Haslerrail G, et al. Effect of medical ozone therapy on renal blood flow and renal. Chin Med J (Engl). 2010;123: 2510\u20132513.", "ArticleIdList": ["21034619"]}, {"Citation": "Neimark AI, Nepomnyashchikh LM, Lushnikova EL, Bakarev M a, Abdullaev N a, Sizov K a. Microcirculation and structural reorganization of the bladder mucosa in chronic cystitis under conditions of ozone therapy. Bull Exp Biol Med. 2014;156: 399\u2013405. doi: 10.1007/s10517-014-2358-7\n", "ArticleIdList": ["10.1007/s10517-014-2358-7", "24771385"]}, {"Citation": "Bayrak O, Erturhan S, Seckiner I, Erbagci A, Ustun A, Karakok M. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder. Urol Ann. 2014;6: 122\u20136. doi: 10.4103/0974-7796.130553\n", "ArticleIdList": ["10.4103/0974-7796.130553", "PMC4021650", "24833822"]}, {"Citation": "Chang JDS, Lu H-S, Chang Y-F, Wang D. Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells. Rheumatol Int. 2005;26: 142\u201351. doi: 10.1007/s00296-004-0526-1\n", "ArticleIdList": ["10.1007/s00296-004-0526-1", "15570426"]}, {"Citation": "Chen H, Yu B, Lu C, Lin Q. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-\u03b1, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Rheumatol Int. 2013;33: 1223\u20137. doi: 10.1007/s00296-012-2529-7\n", "ArticleIdList": ["10.1007/s00296-012-2529-7", "23052485"]}, {"Citation": "Cardelli R, Santis FDE, Dall\u2019olio M, Leonardi M. Osteoarthritis of the Hip Treated by Intra-Articular Infiltration of Oxygen-Ozone and Hyaluronic Acid (Hyalubrix). Int J Ozone Ther. 2008;7: 66\u201369."}, {"Citation": "Yu B, Lin Q, Wang B, Zhu Q, He X. Effect of Intra-Articular Ozone Injection on Degenerative Knee Cartilage in Rats. Int J Ozone Ther. 2010;9: 14\u201320."}, {"Citation": "Mawsouf MN, El-sawalhi MM, Darwish HA, Shaheen AA. Effect of ozone therapy on redox status in experi- mentally induced arthritis. Rev Espa\u00f1ola Ozonioterapia. 2011;1: 32\u201343."}, {"Citation": "Mishra SK, Pramanik R, Das P, Das PP, Palit AK, Roy J, et al. Original Paper Role of intra-articular ozone in osteo-arthritis of knee for functional and symptomatic improvement. Indian J Phys Med Rehabil. 2011;22: 65\u201369."}, {"Citation": "Daif ET. Role of intra-articular ozone gas injection in the management of internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol. Elsevier; 2012;113: e10\u20134. doi: 10.1016/j.tripleo.2011.08.006\n", "ArticleIdList": ["10.1016/j.tripleo.2011.08.006", "22677023"]}, {"Citation": "Calunga JL, Men\u00e9ndez S, Le\u00f3n R, Chang S, Guanche D, Balb\u00edn A, et al.\nApplication of Ozone Therapy in Patients with Knee Osteoarthritis. Ozone Sci Eng. 2012;34: 469\u2013475. doi: 10.1080/01919512.2012.719120", "ArticleIdList": ["10.1080/01919512.2012.719120"]}, {"Citation": "Vaillant JD, Fraga A, D\u00edaz MT, Mallok A, Viebahn-H\u00e4nsler R, Fahmy Z, et al.\nOzone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur J Pharmacol. 2013;714: 318\u201324. doi: 10.1016/j.ejphar.2013.07.034\n", "ArticleIdList": ["10.1016/j.ejphar.2013.07.034", "23911887"]}, {"Citation": "Camelia C, Madalina I, Tatiana M, Marilena P, Oana A, Sanatorium B, et al. The role of ozone therapy in maintaining the articular function and in relieving the pain for patients with knee osteoarthritis. ARS Medica Tomitana. 2014;1: 25\u201329."}, {"Citation": "Fiorela C, Schwartz A. Ozone and Ozonated Growth Factors in the Treatment of Disc Herniation and Discartrosis. Rev Espa\u00f1ola Ozonioterapia. 2013;3: 21\u201333."}, {"Citation": "de N\u00eauton F, Magalh\u00e3es O, Soares SC, Torres JM, Ungaretti A, Cacciacarro MF, et al.\nEffects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: a pilot study. Neuropsychiatr Dis Treat. 2013;9: 1759\u201366. doi: 10.2147/NDT.S48663\n", "ArticleIdList": ["10.2147/NDT.S48663", "PMC3833839", "24259984"]}, {"Citation": "Apuzzo D. An observational retrospective/horizontal study to compare oxygen-ozone therapy and/or global postural re-education in complicated chronic low back pain. Funct Neurol. 2014;29: 1\u20139.", "ArticleIdList": ["PMC4172245", "25014047"]}, {"Citation": "Lintas G, Molinari F, Member S, Simonetti V, Franzini M, Liboni W. Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis. 35th Annual International Conference of the IEEE EMBS. 2013. pp. 6171\u20136174.", "ArticleIdList": ["24111149"]}, {"Citation": "De Souza YM, Fontes B, Martins JO, Sannomiya P, Brito GS, Younes RN, et al.\nEvaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats. Clinics (Sao Paulo). 2010;65: 195\u2013202. doi: 10.1590/S1807-59322010000200012\n", "ArticleIdList": ["10.1590/S1807-59322010000200012", "PMC2827707", "20186304"]}, {"Citation": "Kazancioglu HO, Ezirganli S, Aydin MS. Effects of laser and ozone therapies on bone healing in the calvarial defects. J Craniofac Surg. 2013;24: 2141\u20136. doi: 10.1097/SCS.0b013e3182a244ae\n", "ArticleIdList": ["10.1097/SCS.0b013e3182a244ae", "24220424"]}, {"Citation": "Ozdemir H, Toker H, Balc\u0131 H, Ozer H. Effect of ozone therapy on autogenous bone graft healing in calvarial defects: a histologic and histometric study in rats. J Periodontal Res. 2013;48: 722\u20136. doi: 10.1111/jre.12060\n", "ArticleIdList": ["10.1111/jre.12060", "23452156"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Delgado-Roche L, D\u00edaz-Batista A, P\u00e9rez-Davison G, Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur J Pharmacol. 2012;691: 156\u201362. doi: 10.1016/j.ejphar.2012.07.010\n", "ArticleIdList": ["10.1016/j.ejphar.2012.07.010", "22796450"]}, {"Citation": "Lopes de Jesus CC, dos Santos FC, de Jesus LMOB, Monteiro I, Sant\u2019Ana MSSC, Trevisani VFM. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study. Baak JPA, editor. PLoS One. 2017;12: e0179185\ndoi: 10.1371/journal.pone.0179185\n", "ArticleIdList": ["10.1371/journal.pone.0179185", "PMC5524330", "28738079"]}, {"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in Medicine: The Low-Dose Ozone Concept\u2014Guidelines and Treatment Strategies. Ozone Sci Eng. 2012;34: 408\u2013424. doi: 10.1080/01919512.2012.717847", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Silva MM. Desenvolvimento de protocolo de avalia\u00e7\u00e3o, por determina\u00e7\u00e3o de escore, das altera\u00e7\u00f5es encontradas nas doen\u00e7as articulares em equinos e sua correla\u00e7\u00e3o com evolu\u00e7\u00e3o ap\u00f3s tratamento S\u00e3o Paulo Desenvolvimento de protocolo de avalia\u00e7\u00e3o, por determina\u00e7\u00e3o de. Tese apresentada ao Programa de P\u00f3s- Gradua\u00e7\u00e3o em Cl\u00ednica Cir\u00fargica Veterin\u00e1ria da Faculdade de Medicina Veterin\u00e1ria e Zootecnia da Universidade de S\u00e3o Paulo. Universidade de S\u00e3o Paulo/ Faculdade de Medicina Veterin\u00e1ria e Zootecnia. 2014."}, {"Citation": "Baccarin RYA, Rasera L, Machado TSL, Michelacci YM. Relevance of synovial fluid chondroitin sulphate as a biomarker to monitor polo pony joints. Can J Vet Res. 2014;78: 50\u201360. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878009/pdf/cjvr_01_50.pdf\n", "ArticleIdList": ["PMC3878009", "24396181"]}, {"Citation": "Lee HG, Cowman MK. An Agarose Gel Electrophoretic Method for Analysis of Hyaluronan Molecular Weight Distribution. Anal Biochem. 1994;219: 278\u2013287. doi: 10.1006/abio.1994.1267\n", "ArticleIdList": ["10.1006/abio.1994.1267", "8080084"]}, {"Citation": "Baxter GM. Adams & Stashak\u2019s Lameness in horses. 6a edi\u00e7\u00e3o Oxford: Wiley-Blackwell; 2011."}, {"Citation": "M\u00f6ller I, Bong D, Naredo E, Filippucci E, Carrasco I, Moragues C, et al.\nUltrasound in the study and monitoring of osteoarthritis. Osteoarthr Cartil. 2008;16: 4\u20137. doi: 10.1016/j.joca.2008.06.005\n", "ArticleIdList": ["10.1016/j.joca.2008.06.005", "18760636"]}, {"Citation": "Kidd J, Lu KG, Frazer ML. Atlas of Equine Ultrasonography. 1a edi\u00e7\u00e3o\nSons JW&, editor. Oxford: Wiley Blackwell; 2014. \ndoi: 10.1002/9781118798119", "ArticleIdList": ["10.1002/9781118798119"]}, {"Citation": "Kay AT, Bolt DM, Ishihara A, Rajala-schultz PJ, Bertone AL. Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses. Am J Vet Res. 2008;69: 1646\u20131654. doi: 10.2460/ajvr.69.12.1646\n", "ArticleIdList": ["10.2460/ajvr.69.12.1646", "19046013"]}, {"Citation": "Moraes APL, Moreira JJ, Brossi PM, Machado TSL, Michelacci YM, Baccarin RYA. Short- and long-term effects of platelet-rich plasma upon healthy equine joints: Clinical and laboratory aspects. Can Vet journal La Rev v\u00e9t\u00e9rinaire Can. 2015;56: 831\u20138. Available: http://www.ncbi.nlm.nih.gov/pubmed/26246629%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4502851", "ArticleIdList": ["PMC4502851", "26246629"]}, {"Citation": "Moreira JJ, Moraes APL, Brossi PM, Machado TSL, Michelacci YM, Massoco CO, et al.\nAutologous processed plasma: Cytokine profile and effects upon injection into healthy equine joints. J Vet Sci. 2015;16: 47\u201355. doi: 10.4142/jvs.2015.16.1.47\n", "ArticleIdList": ["10.4142/jvs.2015.16.1.47", "PMC4367149", "25269714"]}, {"Citation": "Steel CM. Equine synovial fluid analysis. Vet Clin North Am Equine Pract. 2008;24: 437\u201354,  viii\ndoi: 10.1016/j.cveq.2008.05.004\n", "ArticleIdList": ["10.1016/j.cveq.2008.05.004", "18652964"]}, {"Citation": "VAN Pelt RW. Interpretation of synovial fluid findings in the horse. J Am Vet Med Assoc. 1974;165: 91\u20135. Available: http://www.ncbi.nlm.nih.gov/pubmed/4134829\n", "ArticleIdList": ["4134829"]}, {"Citation": "McIlwraith CW, Fessler JF, Blevins WE, Page EH, Rebar AH, Van Sickle DC, et al.\nExperimentally induced arthritis of the equine carpus: clinical determinations. Am J Vet Res. 1979;40: 11\u201320. Available: http://www.ncbi.nlm.nih.gov/pubmed/453671\n", "ArticleIdList": ["453671"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?\nMed Gas Res. 2011;1: 29\ndoi: 10.1186/2045-9912-1-29\n", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Jani P, Patel G, Yadav P, Sant L, Jain H. Ozone therapy: the alternative medicine of future. Indian J Phys Med Rehabil. 2012;2: 196\u2013203."}, {"Citation": "Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases. Clin Immunol. 2006;119: 229\u2013240. doi: 10.1016/j.clim.2006.01.016\n", "ArticleIdList": ["10.1016/j.clim.2006.01.016", "16540375"]}, {"Citation": "Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg. 2001;30: 528\u2013538. doi: 10.1053/jvet.2001.28430\n", "ArticleIdList": ["10.1053/jvet.2001.28430", "11704948"]}, {"Citation": "Lamprecht ED, Williams CA. Biomarkers of antioxidant status, inflammation, and cartilage metabolism are affected by acute intense exercise but not superoxide dismutase supplementation in horses. Oxid Med Cell Longev. 2012;2012\ndoi: 10.1155/2012/920932\n", "ArticleIdList": ["10.1155/2012/920932", "PMC3423952", "22919442"]}, {"Citation": "Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987;235: 893\u20135. Available: http://www.ncbi.nlm.nih.gov/pubmed/2433770\n", "ArticleIdList": ["2433770"]}, {"Citation": "Lam FY, Ferrell WR. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience. 1993;52: 443\u2013449. doi: 10.1016/0306-4522(93)90170-K\n", "ArticleIdList": ["10.1016/0306-4522(93)90170-K", "7680789"]}, {"Citation": "Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1993;20: 714\u20137. Available: http://www.ncbi.nlm.nih.gov/pubmed/7684449\n", "ArticleIdList": ["7684449"]}, {"Citation": "Matayoshi T, Goto T, Fukuhara E, Takano H, Kobayashi S, Takahashi T. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. Biochem Biophys Res Commun. 2005;327: 756\u2013764. doi: 10.1016/j.bbrc.2004.12.055\n", "ArticleIdList": ["10.1016/j.bbrc.2004.12.055", "15649411"]}, {"Citation": "Hernanz A, Medina S, De Miguel E, Mart\u00edn-Mola E. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1\u03b2, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthri. Regul Pept. 2003;115: 19\u201324.", "ArticleIdList": ["12873794"]}, {"Citation": "de Grauw JC, van de Lest CHA, van Weeren PR. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther. 2009;11: R35\ndoi: 10.1186/ar2640\n", "ArticleIdList": ["10.1186/ar2640", "PMC2688180", "19272138"]}, {"Citation": "Yang L, Fa X. The effect of substance P on functional proteins in human neutrophil. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002;24: 98\u2013101. Available: http://www.ncbi.nlm.nih.gov/pubmed/12905850\n", "ArticleIdList": ["12905850"]}, {"Citation": "Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51: 249\u201357. doi: 10.1016/j.bone.2012.02.012\n", "ArticleIdList": ["10.1016/j.bone.2012.02.012", "PMC3372675", "22387238"]}, {"Citation": "Hawkins DL, Cargile JL, MacKay RJ, Broome TA, Skelley LA. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Am J Vet Res. 1995;56: 1292\u20139. Available: http://www.ncbi.nlm.nih.gov/pubmed/8928945\n", "ArticleIdList": ["8928945"]}, {"Citation": "Morris EA, McDonald BS, Webb AC, Rosenwasser LJ. Identification of interleukin-1 in equine osteoarthritic joint effusions. Am J Vet Res. 1990;51: 59\u201364. Available: http://www.ncbi.nlm.nih.gov/pubmed/2301820\n", "ArticleIdList": ["2301820"]}, {"Citation": "Alwan WH, Carter D, Bennett D, Edwards GB. Glycosaminog lycans in horses with osteoarthritis. Equine Vet J. 1991;23: 44\u201347.", "ArticleIdList": ["1901787"]}, {"Citation": "Ley C, Svala E, Nilton A, Lindahl A, Eloranta M-L, Ekman S, et al.\nEffects of high mobility group box protein-1, interleukin-1\u03b2, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures. Connect Tissue Res. Taylor & Francis; 2011;52: 290\u2013300. doi: 10.3109/03008207.2010.523803\n", "ArticleIdList": ["10.3109/03008207.2010.523803", "21117899"]}, {"Citation": "Iliakis E, Valadakis V, Vynios DH, Tsiganos CP, Agapitos E. Rationalization of the Activity of Medical Ozone on Intervertebral Disc A Histological and Biochemical Study. Neuroradiol J. SAGE Publications; 2001;14: 23\u201330. doi: 10.1177/19714009010140S105", "ArticleIdList": ["10.1177/19714009010140S105"]}, {"Citation": "Paoloni M, Di Sante L, Cacchio A, Apuzzo D, Marotta S, Razzano M, et al.\nIntramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976). 2009;34: 1337\u201344. doi: 10.1097/BRS.0b013e3181a3c18d\n", "ArticleIdList": ["10.1097/BRS.0b013e3181a3c18d", "19478653"]}, {"Citation": "Ostalowska A, Birkner E, Wiecha M, Kasperczyk S, Kasperczyk A, Kapolka D, et al.\nLipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthr Cartil. 2006;14: 139\u2013145. doi: 10.1016/j.joca.2005.08.009\n", "ArticleIdList": ["10.1016/j.joca.2005.08.009", "16289733"]}, {"Citation": "Surapaneni KM, Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymer in patients with osteoarthritis. Indian J Med Sci. 2007;61: 9\u201314.", "ArticleIdList": ["17197733"]}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, Belmonte G, Gardi C, Virgili F, et al.\nNRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol. 2013;267: 30\u201340. doi: 10.1016/j.taap.2012.12.001\n", "ArticleIdList": ["10.1016/j.taap.2012.12.001", "23253326"]}, {"Citation": "Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radic Res. Taylor & Francis; 2012;46: 1068\u20131075. doi: 10.3109/10715762.2012.693609\n", "ArticleIdList": ["10.3109/10715762.2012.693609", "22583557"]}, {"Citation": "Motohashi H, Yamamoto M. Nrf2\u2013Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004;10: 549\u2013557. doi: 10.1016/j.molmed.2004.09.003\n", "ArticleIdList": ["10.1016/j.molmed.2004.09.003", "15519281"]}, {"Citation": "Zhang DD. Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway. Drug Metab Rev. Taylor & Francis; 2006;38: 769\u2013789. doi: 10.1080/03602530600971974\n", "ArticleIdList": ["10.1080/03602530600971974", "17145701"]}, {"Citation": "Magesh S, Chen Y, Hu L. Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents. Med Res Rev. 2012;32: 687\u2013726. doi: 10.1002/med.21257\n", "ArticleIdList": ["10.1002/med.21257", "PMC3393814", "22549716"]}, {"Citation": "McILWRAITH CW. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review. Equine Vet J. Blackwell Publishing Ltd; 2005;37: 473\u2013482. doi: 10.2746/042516405774480102", "ArticleIdList": ["10.2746/042516405774480102", "16163952"]}, {"Citation": "Palmer JL, Bertone AL, Mcclain H. Assessment of Glycosaminoglycan Concentration in Equine Synovial Fluid as a Marker of Joint Disease. Can J Vet Res. 1995;59: 205\u2013212.", "ArticleIdList": ["PMC1263767", "8521354"]}, {"Citation": "Fuller CJ, Barr AR, Sharif M, Dieppe PA. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthr Cartil. 2001;9: 49\u201355. doi: 10.1053/joca.2000.0349\n", "ArticleIdList": ["10.1053/joca.2000.0349", "11178947"]}, {"Citation": "Tulamo RM, Heiskanen T, Salonen M. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints. Am J Vet Res. 1994;55: 710\u20135. Available: http://www.ncbi.nlm.nih.gov/pubmed/8067622\n", "ArticleIdList": ["8067622"]}, {"Citation": "Hart PH, Ahern MJ, Smith MD, Diseases I. Comparison of the suppressive effects of interleukin-10 and interleukin-4 synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology. 1995;84: 536\u2013542.", "ArticleIdList": ["PMC1415159", "7790026"]}, {"Citation": "Takafuji VA, Mcilwraith CW, Howard RD. Effects of equine recombinant interleukin-1 \u03b1 and interleukin-1 \u03b2 on proteoglycan metabolism and prostaglandin E 2 synthesis in equine articular cartilage explants. Am J Vet Res. 2002;63: 551\u2013558.", "ArticleIdList": ["11939318"]}]}], "History": [{"Year": "2017", "Month": "11", "Day": "25"}, {"Year": "2018", "Month": "5", "Day": "8"}, {"Year": "2018", "Month": "5", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["29813093", "PMC5973567", "10.1371/journal.pone.0197736", "PONE-D-17-41575"]}}]}